Multiple Endocrine Neoplasia Type 1, Type 2A, and Type 2B.
Greenberg LA.
Prim Care. 2024 Sep;51(3):483-494. doi: 10.1016/j.pop.2024.03.006. Epub 2024 May 23.
Multiple endocrine neoplasia type 2: A review.
Mathiesen JS, Effraimidis G, Rossing M, Rasmussen ÅK, Hoejberg L, Bastholt L, Godballe C, Oturai P, Feldt-Rasmussen U.
Semin Cancer Biol. 2022 Feb;79:163-179. doi: 10.1016/j.semcancer.2021.03.035. Epub 2021 Apr 1.
Molecular Diagnosis and Treatment of Multiple Endocrine Neoplasia Type 2B in Ethnic Han Chinese.
Zhang ZW, Guo X, Qi XP.
Endocr Metab Immune Disord Drug Targets. 2021;21(3):534-543. doi: 10.2174/1871530320666200910112230.
Multiple endocrine neoplasia type 2B syndrome.
Malhotra R, Goyal A, Shamim SA.
QJM. 2021 Jul 28;114(4):272-273. doi: 10.1093/qjmed/hcaa184.
Multiple endocrine neoplasia type 2B--genetic basis and clinical expression.
Lee NC, Norton JA.
Surg Oncol. 2000 Nov;9(3):111-8. doi: 10.1016/s0960-7404(00)00038-4.
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma.
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
Multiple endocrine neoplasia type 2B and Hirschsprung's disease.
Kapur RP.
Clin Gastroenterol Hepatol. 2005 May;3(5):423-31. doi: 10.1016/s1542-3565(04)00676-7.
Multiple endocrine neoplasia type 2B: Frequency of physical stigmata-Results of the GPOH-MET registry.
Redlich A, Lessel L, Petrou A, Mier P, Vorwerk P.
Pediatr Blood Cancer. 2020 Feb;67(2):e28056. doi: 10.1002/pbc.28056. Epub 2019 Nov 13.
Tumor-to-Tumor Metastasis of Medullary Thyroid Carcinoma to Paraganglioma in a Multiple Endocrine Neoplasia Type 2B Patient: A Case Report and Literature Review.
Takido N, Saito R, Okada K, Kanai N, Shono Y, Mitsugashira H, Matsumura M, Sasaki K, Miyazawa K, Fujio A, Tokodai K, Murakami K, Sasano H, Unno M, Ishida T, Kamei T.
Tohoku J Exp Med. 2023 Sep 20;261(1):75-81. doi: 10.1620/tjem.2023.J058. Epub 2023 Jul 20.
Cystic ovarian teratoma as a novel tumor and growth hormone deficiency as a new condition presenting in Multiple Endocrine Neoplasia type 2B: Case reports and review of the literature.
Pomahacova R, Paterova P, Nykodymova E, Vaclavikova E, Sykorova P, Personova K, Katra R, Subrt I, Sykora J.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Mar;166(1):105-111. doi: 10.5507/bp.2021.051. Epub 2021 Aug 24.
